The stock of Vaxart Inc. (NASDAQ:VXRT) decreased by -$0.01 on Friday to finish at $0.79, down -1.89 percent. The last five days have seen an average of 1,862,580 shares of common stock traded. 7 times new highs were reached in the current year, with a fall of -$0.1736. The average number of shares traded over the last 20 days was 1,176,590, while the average volume over the last 50 days totaled 1,804,766.
VXRT stock appreciated 4.97% since last month. On 08/16/23, the company’s shares reached a one-month low of $0.6660. The stock touched a high of $3.62 on 05/16/23, after rallying from a low of $0.56 in 52 weeks. The price of VXRT stock has declined by -18.07% or -$0.1736 this year, reaching a new high 7 times. Still, the stock price is down -78.25% from the 52-week high.
Insider Transactions
VXRT stock investors should be aware that Vaxart Inc. (VXRT) stock had its last reported insider trading activity 243 days ago on Dec 28. On Dec 28, Director Watson W. Mark acquired 20,000 shares at $0.76 each. This transaction resulted in the insider spending $15,140.
Valuation Metrics
Beta for the stock is 0.65. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 58.12, the price-to-book (PB) ratio of 1.29.
Financial Health
For the three months ended June 29, Vaxart Inc.’s quick ratio was 5.10, while its current ratio was 5.10, indicating its ability to pay off its debt. Based on annual data, it had gross profit of $114.69 million and revenue of $0.11 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. VXRT’s return on assets (ROA) during the last 12 months has been -69.40%. There was a -97.40% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -99.00%.
Earnings Surprise
According to Vaxart Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $1.36 million, while revenues rose by 100.0% to $0.68 million. It was predicted that Vaxart Inc.’s quarterly earnings would be -$0.16, but it ended up being -$0.18, beating the consensus by 11.10%. EBITDA was -$21.11 million for the quarter. At the end of Vaxart Inc.’s most recent quarter ended June 29, its liabilities totaled 37.58 million, while its total debt was $21.0 million. Equity owned by shareholders amounts to $151.97 million.
Technical Picture
Here’s a quick look at Vaxart Inc.’s (VXRT) price momentum from a technical perspective. As of 25 August, the RSI 9-day stood at 55.47%, suggesting the stock is Neutral, with a 67.32% historical volatility rate.
The stochastic %K and %D were 77.96% and 81.06% respectively, while the average true range (ATR) was 0.0547. Based on the 14-day stochastic reading of 65.25%, the RSI (14) reading is 52.68%. On the 9-day MACD Oscillator, the stock is at 0.0500, and the 14-day reading is at 0.0650.
Analyst Ratings
Analysts have assigned Vaxart Inc. (VXRT) an Overweight rating. VXRT is a stock that is recommended for selling by 0 brokerage firms, while 1 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 2 others recommend it as a buy.
What is VXRT’s price target for the next 12 months?
The current consensus forecast for the stock is between $1.50 and $8.00, with a median target price of $4.00. In analyzing these forecasts, the average price target given by analysts for Vaxart Inc. (VXRT) is $4.50.
